Veer Health Targets Rs 40 Cr Revenue in FY26

New Delhi, Jul 24 (PTI) Veer Health Care on Thursday said it is aiming to more than double its revenue to Rs 40 crore in the current fiscal year, mainly due to expansion in international markets.

This growth outlook is fuelled by strong export momentum, full-capacity operations, and anticipated expansion into new international markets, a company statement said.

Veer Health Care Ltd, a leading manufacturer of ayurvedic and natural personal care products under the Ayuveer brand, has projected total revenues of Rs 35-40 crore for the financial year 2025-26, with an expected Profit After Tax (PAT) margin of 10 per cent, according to the statement.

The company's Vapi-based manufacturing facility is now running at full capacity to meet surging domestic and international demand, with operational efficiency expected to further support profitability.

Veer Health Care Ltd reported a revenue of Rs 17.88 crore for the FY 2024-2025, marking a rise of 22.38 per cent year-on-year.

Following its USFDA compliance approval in May 2025, Veer Health Care has seen a notable uptick in international interest.

The company has already completed three Full Container Load (FCL) export shipments to the U.S., with new orders scheduled for dispatch within 30 days. It plans to scale up to 4-5 shipments per month for US clients, strengthening its revenue stream from the US market.

Simultaneously, Veer Health Care is in advanced discussions with a major Russian corporate group to supply its ayurvedic oral care products, with market entry expected anytime soon. This marks a significant step in the company's strategy to establish a broader global footprint for its Ayuveer product line.

In addition to its core ayurvedic portfolio, Veer Health Care is actively pursuing entry into the US medical devices market. The company is progressing toward USFDA compliance for its upcoming range of products, including ventilators, defibrillators, and infusion pumps.

New business divisions such as Hospital Care, in collaboration with medical equipment exporters, and VecrPlast, focused on precision toothbrush manufacturing, further reinforce the company's diversified growth approach.

"With full-capacity operations and strategic diversification into medical devices and oral care manufacturing, we're confident of achieving Rs 35-40 crore in revenue this year and reaching Rs 100 crore within the next 2-3 years," said Bhavin Shah, Managing Director at Veer Health Care. PTI KKS 1.0.